INTERNAL RADIOTHERAPY OF LIVER CANCER_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

Department of Hepato-Bilio-Pancreatic Surgery, First Affiliated Hospital,West China University of Medical Science, Chengdu 610041;

Corresponding?author：

Keywords：

Liver cancer Internal radiotherapy

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To study the development of internal radiotherapy for liver cancer and the relationship between effects and radiation doses.
Methods Literature about internal radiotherapy of liver cancer were collected and reviewed.
Results The rational selection of radioactive microsphere,the appropriate control of radiation dosage and the path of internal radiotherapy are crucial in improving the therapy effects and decreasing the complications. Conclusion The two-stage operation of liver cancer which is on the base of combining chemotherapy, radiotherapy and immunotherapy is the way to go of liver cancer therapy.

Citation： LI Zhihui,YAN Lnan.. INTERNAL RADIOTHERAPY OF LIVER CANCER. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2001, 8(4): 273-275. doi: Copy

1.	Grady ED. Intrahepaticaterial 90 Yttriumresin spheres to treat liver cancer 〔Ｊ〕.J Nucle Med Bio,1978; 5(6)∶235.
2.	Mantravadi RVP, Spigos DG, Tan WS, et al. Intraarterial Yttrium 90 in the treatment of hepatic magilinancy 〔Ｊ〕. Radiology,1982; 142(3)∶783.
3.	Nakakuma K, Tashiro S, Hiraoka T, et al. Studies on the anticancer treatment with oily anticancer drug injected into the ligated hepatic artery for liver cancer 〔Ｊ〕,Nichidoku Iho,1979; 24(4)∶675.
4.	Shimabukuro K. Possibility of radiotherapy of hepatic cancer by transcatheter arterial emboliztion with radioactive lipiodol 〔Ｊ〕,Nippon Acta Radiol,1984; 44(1)∶96.
5.	Prinzmetal M,Ornitz EM,Simkin B, et al. Arteriovenous anastomoses in liver,spleen and lungs 〔Ｊ〕. Am J Physiol,1948; 152(1)∶48.
6.	Sylvain H, TsuiChun K, Francis A,et al.Hepatocellular carcinoma:pilot trial of treatment with Y90 microspheres 〔Ｊ〕.Radiology,1989; 172(3)∶857.
7.	嚴律南，李立，陳曉理等. 32磷玻璃微球肝動脈栓塞治療晚期肝癌的初步應用〔Ｊ〕. 中華外科雜志， 1996； 34（9）∶526.
8.	周淑珍，劉國廉，祝宵霞等. 放射性釔90玻璃微球制劑局部注射對裸鼠移植性肝癌的療效觀察〔Ｊ〕. 中華放射醫學與防護雜志， 1994； 14（2）∶114.
9.	Tian JH, Xu BX, Zhang JM, et al. Ultrasoundguided internal radiotherapy using yttrium90glass microspheres for liver malignancies 〔Ｊ〕. J Nucl Med, 1996; 3(6)∶958.
10.	Okazaki M, Ymasakisono H. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy 〔Ｊ〕. Hepatogastroenterology, 1993; 40(4)∶320.
11.	Narihide G, Toshihisa N, Mitsuo E, et al. Nourishment of hepatocellular carcinoma cells through the portal blood flow with and without transcathete arterial embolization 〔Ｊ〕. Cancer, 1995; 76(5)∶738.
12.	劉鵬程. 經門靜脈注入碘油化療的治療肝癌的實驗研究〔Ｊ〕. 同濟醫科大學學報， 1994； 23（4）∶312.
13.	Zeng ZC, Tang ZY, Liu KD, et al. Human anti(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131Ilabeled Hepama1 mAb. Preliminary results and disussion 〔Ｊ〕. Cancer Immunol Immunother, 1984; 39(5)∶332.
14.	施樂華，吳孟超，陳漢等. 肝癌注射治療劑量131碘抗肝癌McAb的RII 〔Ｊ〕. 中華核醫學雜志， 1994 ；14（1）∶32.
15.	姜維關，于連英，周淑珍等. 釔90玻璃微球制劑局部注射對裸鼠移植性人肝癌的療效觀察〔Ｊ〕. 中國腫瘤臨床， 1994； 1（11）∶861.
16.	Andrews JC, Walker SC, Ackermann RJ, et al. Hepatic radioembolization with yittrium90 containing glass microspheres preliminary results and clinical followup 〔Ｊ〕. J Nucl Med, 1994; 35(10)∶1637.
17.	Lau WY, Leung WT, Ho S, et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yittium90 microspheres： phrase I and Ⅱ study 〔Ｊ〕. Br J Cancer, 1994; 70(5)∶994.
18.	Raoul L, Guyader D, Bretagne F, et al. Prospective randomized trial of chemoembolization versus intraarterial injection of 131IIabeledIodized oil in the treatment of hepatocellular carcinoma 〔Ｊ〕. J Hepatology, 1997; 26(5)∶1156.
19.	Zeng ZC, Tang ZY, Xie H, et al . Radioimmunotherapy for unresectable hepatocellular carcinomausing 131Ihepama1 Mab: preliminary result 〔Ｊ〕. J Cancer Res Clin Oncol, 1993; 119(5)∶257.
20.	李立，嚴律南，吳宏斌等. 肝動脈栓塞術后肝臟能量代謝變化的探討〔Ｊ〕. 中華放射學雜志， 1997； 31（5）∶315.
21.	Ho S, Lau WY, Leung TW, et al. Clinical evaluation of the partition model for estimating radiation doses from yttrium90 microspheres in the treatment of hepatic cancer 〔Ｊ〕. Eur J Nucl Med, 1997; 24(3)∶293.
22.	吳建新. 原發性肝癌動脈化療栓塞后5種并發癥的診治〔Ｊ〕. 江蘇醫藥， 1993； 19（8）∶442.

1. Grady ED. Intrahepaticaterial 90 Yttriumresin spheres to treat liver cancer 〔Ｊ〕.J Nucle Med Bio,1978; 5(6)∶235.
2. Mantravadi RVP, Spigos DG, Tan WS, et al. Intraarterial Yttrium 90 in the treatment of hepatic magilinancy 〔Ｊ〕. Radiology,1982; 142(3)∶783.
3. Nakakuma K, Tashiro S, Hiraoka T, et al. Studies on the anticancer treatment with oily anticancer drug injected into the ligated hepatic artery for liver cancer 〔Ｊ〕,Nichidoku Iho,1979; 24(4)∶675.
4. Shimabukuro K. Possibility of radiotherapy of hepatic cancer by transcatheter arterial emboliztion with radioactive lipiodol 〔Ｊ〕,Nippon Acta Radiol,1984; 44(1)∶96.
5. Prinzmetal M,Ornitz EM,Simkin B, et al. Arteriovenous anastomoses in liver,spleen and lungs 〔Ｊ〕. Am J Physiol,1948; 152(1)∶48.
6. Sylvain H, TsuiChun K, Francis A,et al.Hepatocellular carcinoma:pilot trial of treatment with Y90 microspheres 〔Ｊ〕.Radiology,1989; 172(3)∶857.
7. 嚴律南，李立，陳曉理等. 32磷玻璃微球肝動脈栓塞治療晚期肝癌的初步應用〔Ｊ〕. 中華外科雜志， 1996； 34（9）∶526.
8. 周淑珍，劉國廉，祝宵霞等. 放射性釔90玻璃微球制劑局部注射對裸鼠移植性肝癌的療效觀察〔Ｊ〕. 中華放射醫學與防護雜志， 1994； 14（2）∶114.
9. Tian JH, Xu BX, Zhang JM, et al. Ultrasoundguided internal radiotherapy using yttrium90glass microspheres for liver malignancies 〔Ｊ〕. J Nucl Med, 1996; 3(6)∶958.
10. Okazaki M, Ymasakisono H. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy 〔Ｊ〕. Hepatogastroenterology, 1993; 40(4)∶320.
11. Narihide G, Toshihisa N, Mitsuo E, et al. Nourishment of hepatocellular carcinoma cells through the portal blood flow with and without transcathete arterial embolization 〔Ｊ〕. Cancer, 1995; 76(5)∶738.
12. 劉鵬程. 經門靜脈注入碘油化療的治療肝癌的實驗研究〔Ｊ〕. 同濟醫科大學學報， 1994； 23（4）∶312.
13. Zeng ZC, Tang ZY, Liu KD, et al. Human anti(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131Ilabeled Hepama1 mAb. Preliminary results and disussion 〔Ｊ〕. Cancer Immunol Immunother, 1984; 39(5)∶332.
14. 施樂華，吳孟超，陳漢等. 肝癌注射治療劑量131碘抗肝癌McAb的RII 〔Ｊ〕. 中華核醫學雜志， 1994 ；14（1）∶32.
15. 姜維關，于連英，周淑珍等. 釔90玻璃微球制劑局部注射對裸鼠移植性人肝癌的療效觀察〔Ｊ〕. 中國腫瘤臨床， 1994； 1（11）∶861.
16. Andrews JC, Walker SC, Ackermann RJ, et al. Hepatic radioembolization with yittrium90 containing glass microspheres preliminary results and clinical followup 〔Ｊ〕. J Nucl Med, 1994; 35(10)∶1637.
17. Lau WY, Leung WT, Ho S, et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yittium90 microspheres： phrase I and Ⅱ study 〔Ｊ〕. Br J Cancer, 1994; 70(5)∶994.
18. Raoul L, Guyader D, Bretagne F, et al. Prospective randomized trial of chemoembolization versus intraarterial injection of 131IIabeledIodized oil in the treatment of hepatocellular carcinoma 〔Ｊ〕. J Hepatology, 1997; 26(5)∶1156.
19. Zeng ZC, Tang ZY, Xie H, et al . Radioimmunotherapy for unresectable hepatocellular carcinomausing 131Ihepama1 Mab: preliminary result 〔Ｊ〕. J Cancer Res Clin Oncol, 1993; 119(5)∶257.
20. 李立，嚴律南，吳宏斌等. 肝動脈栓塞術后肝臟能量代謝變化的探討〔Ｊ〕. 中華放射學雜志， 1997； 31（5）∶315.
21. Ho S, Lau WY, Leung TW, et al. Clinical evaluation of the partition model for estimating radiation doses from yttrium90 microspheres in the treatment of hepatic cancer 〔Ｊ〕. Eur J Nucl Med, 1997; 24(3)∶293.
22. 吳建新. 原發性肝癌動脈化療栓塞后5種并發癥的診治〔Ｊ〕. 江蘇醫藥， 1993； 19（8）∶442.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

INTERNAL RADIOTHERAPY OF LIVER CANCER

Abstract Full text Figures/Tables Video References Cited by

Format

Content